Bath & Body Works, Inc. (NYSE:BBWI) CEO Gina Boswell Acquires 6,000 Shares

Bath & Body Works, Inc. (NYSE:BBWI) CEO Gina Boswell purchased 6,000 shares of the business’s stock in a transaction on Wednesday, October 9th. The shares were acquired at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the acquisition, the chief executive officer now directly owns 242,987 shares in the company, valued at approximately $7,202,134.68. This represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Bath & Body Works Stock Up 0.7 %

Bath & Body Works stock traded up $0.21 during midday trading on Friday, reaching $31.43. The stock had a trading volume of 4,838,512 shares, compared to its average volume of 3,699,097. The firm has a market capitalization of $6.89 billion, a PE ratio of 7.61, a P/E/G ratio of 0.94 and a beta of 1.77. Bath & Body Works, Inc. has a 12 month low of $26.20 and a 12 month high of $52.99. The firm’s 50-day moving average price is $30.92 and its 200 day moving average price is $39.29.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The company had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Equities research analysts expect that Bath & Body Works, Inc. will post 3.18 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 6th. Stockholders of record on Friday, August 23rd were given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.55%. The ex-dividend date of this dividend was Friday, August 23rd. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.37%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on BBWI shares. Morgan Stanley lowered their target price on Bath & Body Works from $56.00 to $51.00 and set an “overweight” rating on the stock in a research report on Thursday, September 5th. JPMorgan Chase & Co. lowered their price objective on shares of Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a report on Thursday, August 29th. Evercore ISI reduced their price objective on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a report on Wednesday, August 28th. Piper Sandler lowered their target price on shares of Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating on the stock in a report on Thursday, July 11th. Finally, Robert W. Baird dropped their price target on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a research report on Thursday, August 29th. Eight analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, Bath & Body Works presently has an average rating of “Moderate Buy” and a consensus price target of $42.35.

Institutional Investors Weigh In On Bath & Body Works

Several hedge funds and other institutional investors have recently modified their holdings of BBWI. Anomaly Capital Management LP bought a new position in Bath & Body Works in the 2nd quarter valued at $113,995,000. Lone Pine Capital LLC boosted its stake in Bath & Body Works by 15.8% during the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock valued at $441,871,000 after buying an additional 1,547,399 shares during the period. Vanguard Group Inc. grew its position in Bath & Body Works by 4.2% during the first quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock worth $1,370,458,000 after buying an additional 1,102,124 shares in the last quarter. Interval Partners LP raised its holdings in shares of Bath & Body Works by 230.0% in the 2nd quarter. Interval Partners LP now owns 1,280,593 shares of the company’s stock valued at $50,007,000 after acquiring an additional 892,488 shares in the last quarter. Finally, Ceredex Value Advisors LLC bought a new stake in shares of Bath & Body Works during the 2nd quarter valued at about $25,867,000. 95.14% of the stock is currently owned by institutional investors.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.